Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia

Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies

(2009) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

(2009) C. S. Lunde et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model

(2009) S. S. Hegde et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

(2008) K. M. Krause et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

(2008) D. C. Draghi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative

(2008) D. C. Draghi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy

(2008) R. G. Masterton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY